Qelbree 17772-0133
Generic: Viloxazine Hydrochloride
Product NDC
17772-0133- Manufacturer
- Supernus Pharmaceuticals, Inc
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 2, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA211964
Need to source Qelbree? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Viloxazine Hydrochloride | 200 mg/1 |
Drug Class
Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2B6 Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(5)
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-01)
7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-07)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-30)
60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-60)
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-90)